W. David Jarvis

5.9k citations

51 papers · 5.2k indexed · 1 hit paper · h-index 31

Co-authors: Steven Grant Richard Kolesnick Rebecca S. Traylor Frank A. Fornari Éva Szabó Michael J. Birrer David A. Gewirtz Marcel Verheij
Topics: Cell death mechanisms and regulation (12 papers)Sphingolipid Metabolism and Signaling (11 papers)Protein Kinase Regulation and GTPase Signaling (10 papers)
Cited by: Molecular Biology Cell Biology Toxicology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States France Japan

In The Last Decade

W. David Jarvis

51 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

1996 1.6k citations W. David Jarvis, Steven Grant et al. profile →

Peers

Countries citing papers authored by W. David Jarvis

Since Specialization

Citations

This map shows the geographic impact of W. David Jarvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. David Jarvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. David Jarvis more than expected).

Fields of papers citing papers by W. David Jarvis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. David Jarvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. David Jarvis. The network helps show where W. David Jarvis may publish in the future.

Co-authorship network of co-authors of W. David Jarvis

This figure shows the co-authorship network connecting the top 25 collaborators of W. David Jarvis. A scholar is included among the top collaborators of W. David Jarvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. David Jarvis. W. David Jarvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues 2010 ·Arthritis & Rheumatism ·Mohammed F. Shamji,Lori A. Setton,W. David Jarvis,Stephen So,Jun Chen,Liufang Jing,Robert Bullock,Robert E. Isaacs,Christopher R. Brown,William J. Richardson	389
2	Presence of a peptide component of thymosin fraction-5 manifesting discrete cytostatic properties in HL-60 human promyelocytic leukemia cells 2005 ·International Immunopharmacology ·Bryan L. Spangelo,Melissa Pompilius,(unknown),Nicole Stevens,(unknown),(unknown),Mahnaz Badamchian,(unknown),W. David Jarvis	7
3	Downregulation of δ CaM kinase II in human tumor cells 1999 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Robert M. Tombes,Ross B. Mikkelsen,W. David Jarvis,Steven Grant	26
4	Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53 1999 ·Oncogene ·(unknown),Roy H. Decker,(unknown),(unknown),W. David Jarvis,Victoria M. Richon,Mats Ehinger,Paul B. Fisher,Steven Grant	244
5	The role of ceramide in the cellular response to cytotoxic agents 1998 ·Current Opinion in Oncology ·W. David Jarvis,Steven Grant	38
6	Evidence for Involvement of Mitogen-Activated Protein Kinase, Rather than Stress-Activated Protein Kinase, in Potentiation of 1-β-d-Arabinofuranosylcytosine-Induced Apoptosis by Interruption of Protein Kinase C Signaling 1998 ·Molecular Pharmacology ·W. David Jarvis,Frank A. Fornari,Robert M. Tombes,Ravi Kumar Erukulla,Robert Bittman,Gary K. Schwartz,Paul Dent,Steven Grant	80
7	Agents that Down-Regulate or Inhibit Protein Kinase C Circumvent Resistance to 1-β-D-Arabinofuranosylcytosine-Induced Apoptosis in Human Leukemia Cells that Overexpress Bcl-2 1997 ·Molecular Pharmacology ·Shujie Wang,Julie A. Vrana,(unknown),Alex J. Freemerman,W. David Jarvis,Lora B. Kramer,Geoffrey W. Krystal,Paul Dent,Steven Grant	68
8	Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis 1997 ·Cell Death and Differentiation ·(unknown),Julie A. Vrana,Alex J. Freemerman,W. David Jarvis,John C. Reed,Lawrence Boise,Steven Grant	5
9	Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death 1996 ·International Journal of Radiation Biology ·(unknown),W. David Jarvis,Michael S. Orr,Steven Grant,David A. Gewirtz	9
10	Modulation of Protein Kinase C Activity and Calcium-Sensitive Isoform Expression in Human Myeloid Leukemia Cells by Bryostatin 1: Relationship to Differentiation and Ara-C-Induced Apoptosis 1996 ·Experimental Cell Research ·(unknown),Amy Turner,Alex J. Freemerman,Zhiliang Wang,Lora B. Kramer,W. David Jarvis	24
11	Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. 1996 ·Endocrinology ·(unknown),W. David Jarvis	35
12	Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin 1996 ·Biochemical Pharmacology ·Frank A. Fornari,W. David Jarvis,Steven Grant,Michael S. Orr,Joyce K. Randolph,(unknown),David A. Gewirtz	63
13	Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells 1994 ·Biochemical Pharmacology ·W. David Jarvis,Lawrence F. Povirk,Amy Turner,Rebecca S. Traylor,David A. Gewirtz,George R. Pettit,Steven Grant	81
14	Effects of bryostatin 1 and rGM‐CSF on the metabolism of 1‐β‐d‐arabinofuranosylcytosine in human leukaemic myeloblasts 1992 ·British Journal of Haematology ·Steven Grant,W. David Jarvis,Amy Turner,(unknown),George R. Pettit	9
15	Induction of Interleukin-6 Release by Interleukin-1 in Rat Anterior Pituitary Cellsin Vitro: Evidence for an Eicosanoid-Dependent Mechanism* 1991 ·Endocrinology ·Bryan L. Spangelo,W. David Jarvis,Allan M. Judd,Robert M. MacLeod	55
16	Physiological and biochemical effects of bradykinin and lys-bradykinin in pituitary cells 1990 ·Molecular and Cellular Endocrinology ·(unknown),Allan M. Judd,W. David Jarvis,Ivan S. Login,Robert M. MacLeod	2
17	Calcitonin Decreases Thyrotropin-Releasing Hormone-Stimulated Prolactin Release through a Mechanism That Involves Inhibition of Inositol Phosphate Production* 1990 ·Endocrinology ·Allan M. Judd,Toshiro Kubota,(unknown),W. David Jarvis,Bryan L. Spangelo,Robert M. MacLeod	26
18	Attenuation of Anterior Pituitary Phosphoinositide Phosphorylase Activity by the D₂Dopamine Receptor* 1988 ·Endocrinology ·W. David Jarvis,Allan M. Judd,Robert M. MacLeod	36
19	Attenuation of pituitary polyphosphoinositide metabolism by protein kinase C activation 1987 ·Molecular and Cellular Endocrinology ·Allan M. Judd,W. David Jarvis,Robert M. MacLeod	15
20	Thymosin Fraction 5 Stimulates Prolactin and Growth Hormone Release from Anterior Pituitary Cellsin Vitro* 1987 ·Endocrinology ·Bryan L. Spangelo,Allan M. Judd,(unknown),Ivan S. Login,W. David Jarvis,Mahnaz Badamchian,Allan L. Goldstein,Robert M. MacLeod	35

About W. David Jarvis

W. David Jarvis is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 51 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (12 papers), Sphingolipid Metabolism and Signaling (11 papers) and Protein Kinase Regulation and GTPase Signaling (10 papers). The work is most often cited by research in Molecular Biology (3.8k citations), Cell Biology (572 citations) and Toxicology (112 citations). W. David Jarvis has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Steven Grant, Richard Kolesnick, Rebecca S. Traylor, Frank A. Fornari, Éva Szabó, Michael J. Birrer, David A. Gewirtz, Marcel Verheij, Ron Bose and Adriana Haimovitz‐Friedman. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact